Bank of Montreal’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-69,978
| Closed | -$1.41M | – | 4032 |
|
|
2021
Q3 | $1.41M | Buy |
69,978
+16,853
| +32% | +$465K | ﹤0.01% | 2280 |
|
|
2021
Q2 | $1.95M | Sell |
53,125
-24,703
| -32% | -$757K | ﹤0.01% | 2078 |
|
|
2021
Q1 | $2.06M | Sell |
77,828
-39,005
| -33% | -$996K | ﹤0.01% | 1790 |
|
|
2020
Q4 | $2.82M | Sell |
116,833
-22,195
| -16% | -$489K | ﹤0.01% | 1670 |
|
|
2020
Q3 | $2.57M | Sell |
139,028
-6,367
| -4% | -$132K | ﹤0.01% | 1564 |
|
|
2020
Q2 | $3.69M | Sell |
145,395
-42,362
| -23% | -$913K | ﹤0.01% | 1324 |
|
|
2020
Q1 | $3.44M | Buy |
187,757
+139,226
| +287% | +$2.71M | ﹤0.01% | 1161 |
|
|
2019
Q4 | $1.07M | Buy |
48,531
+43,990
| +969% | +$885K | ﹤0.01% | 2230 |
|
|
2019
Q3 | $65K | Buy |
4,541
+243
| +6% | +$3.47K | ﹤0.01% | 3507 |
|
|
2019
Q2 | $68K | Buy |
+4,298
| New | +$58.4K | ﹤0.01% | 3546 |
|
|
2019
Q1 | – | Sell |
-760
| Closed | -$8K | – | 4936 |
|
|
2018
Q4 | $8K | Buy |
760
+446
| +142% | +$5.87K | ﹤0.01% | 3966 |
|
|
2018
Q3 | $5K | Sell |
314
-73,002
| -100% | -$1.06M | ﹤0.01% | 4137 |
|
|
2018
Q2 | $898K | Buy |
+73,316
| New | +$921K | ﹤0.01% | 2060 |
|
|
2017
Q2 | – | Sell |
-23,000
| Closed | -$78K | – | 4344 |
|
|
2017
Q1 | $78K | Sell |
23,000
-4,609
| -17% | -$13K | ﹤0.01% | 2928 |
|
|
2016
Q4 | $83K | Buy |
27,609
+5,000
| +22% | +$17.8K | ﹤0.01% | 2921 |
|
|
2016
Q3 | $133K | Sell |
22,609
-2,000
| -8% | -$7.01K | ﹤0.01% | 2624 |
|
|
2016
Q2 | $74K | Buy |
24,609
+22,232
| +935% | +$91.3K | ﹤0.01% | 2927 |
|
|
2016
Q1 | $13K | Buy |
2,377
+2,186
| +1,145% | +$13.8K | ﹤0.01% | 3540 |
|
|
2015
Q4 | $2K | Buy |
+191
| New | +$2.19K | ﹤0.01% | 4014 |
|
|
2014
Q3 | – | Sell |
-90
| Closed | -$2K | – | 4540 |
|
|
2014
Q2 | $2K | Buy |
+90
| New | +$1.63K | ﹤0.01% | 4532 |
|
Other funds holding DRNA
Bank of Montreal's DRNA Position: Q4 2021 in Review
Bank of Montreal sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 69,978 shares — an estimated $1.41M sold.
Bank of Montreal first reported a position in DRNA in Q2 2014 and held it in 20 quarters. The position peaked at $3.69M in Q2 2020. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.
- Bank of Montreal reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
- Bank of Montreal sold 69,978 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $1.41M.
- Bank of Montreal first reported a position in Dicerna Pharmaceuticals, Inc. in Q2 2014 and held it in 20 quarters.
- Bank of Montreal's Dicerna Pharmaceuticals, Inc. position peaked at $3.69M in Q2 2020.
- 1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.
Based on Bank of Montreal's 13F filing for Q4 2021, filed 11 Feb 2022.